Stage III solid tumor cancer
Showing 26 - 50 of >10,000
Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in
Recruiting
- Advanced Pancreatic Carcinoma
- +27 more
- Biopsy
- Talazoparib
-
Gainesville, Florida
- +3 more
Jan 3, 2023
Breast Cancer Undergoing Neoadjuvant Therapy
Recruiting
- Stage I-III Breast Cancer
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 13, 2022
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor
Recruiting
- Advanced Malignant Solid Neoplasm
- +7 more
- BET Bromodomain Inhibitor ZEN-3694
- Talazoparib
-
Atlanta, Georgia
- +2 more
Nov 3, 2022
Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester
Recruiting
- Advanced Pancreatic Carcinoma
- +9 more
- Endoscopic Ultrasound
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2022
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1
Not yet recruiting
- Advanced Fallopian Tube Carcinoma
- +10 more
- Wee1 Inhibitor ZN-c3
-
Portland, OregonOHSU Knight Cancer Institute
Jan 25, 2023
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States
Terminated
- Metastatic Malignant Solid Neoplasm
- +8 more
- Navitoclax
- Vistusertib
-
Los Angeles, California
- +13 more
Oct 7, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Enrolling by invitation
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Aromatherapy with Essential Oils and Virtual Reality
-
Portland, OregonOHSU Knight Cancer Institute
Jul 21, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)
Not yet recruiting
- Stage III NSCLC
- Surgery
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Feb 21, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)
Not yet recruiting
- Hepatocellular Carcinoma
- Colorectal Cancer
- Patient-Derived Tumor Organoids
-
Hong Kong, N.t., Hong KongEndoscopy Centre, Prince of Wales Hospital
Oct 12, 2023
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +17 more
- Biopsy
- +3 more
-
Augusta, Georgia
- +4 more
Jan 25, 2023
Defining Clinical Potential of Mass Response asBiomarker for
Recruiting
- Stage III Breast Cancer
- +5 more
-
Columbus, GeorgiaColumbus Regional Research Institute, John B. Amos Cancer Center
Jul 13, 2022